Microfluidic cell squeeze-based vaccine comes into clinical investigation
Authors:
Open Access
- 4 May 2023
- journal article
- editorial
- Published by Springer Nature in npj Vaccines
- Vol. 8 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor ActivityThe Journal of Immunology, 2022
- Microfluidic mechanoporation for cellular delivery and analysisMaterials Today Bio, 2021
- 48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumorsAnnals of Oncology, 2021
- High-throughput nuclear delivery and rapid expression of DNA via mechanical and electrical cell-membrane disruptionNature Biomedical Engineering, 2017
- In vitro and ex vivo strategies for intracellular deliveryNature, 2016
- Cell Squeezing as a Robust, Microfluidic Intracellular Delivery PlatformJournal of Visualized Experiments, 2013
- A vector-free microfluidic platform for intracellular deliveryProceedings of the National Academy of Sciences, 2013